Exposure to methamidophos at adulthood adversely affects serotonergic biomarkers in the mouse brain  by Lima, Carla S. et al.
NeuroToxicology 32 (2011) 718–724Exposure to methamidophos at adulthood adversely affects serotonergic
biomarkers in the mouse brain
Carla S. Lima a, Andre´ L. Nunes-Freitas a, Anderson Ribeiro-Carvalho a,c, Cla´udio C. Filgueiras a,
Alex C. Manha˜es a, Armando Meyer b, Yael Abreu-Villac¸a a,*
a Laborato´rio de Neuroﬁsiologia, Departamento de Cieˆncias Fisiolo´gicas, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, Av. Prof. Manoel de
Abreu 444, 5 andar – Vila Isabel, Rio de Janeiro, RJ 20550-170, Brazil
b Instituto de Estudos em Sau´de Coletiva e Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Av. Um. Prac¸a Jorge Machado Moreira, 100, Cidade Universita´ria, Rio de
Janeiro, RJ 21941-598, Brazil
c Instituto Federal de Educac¸a˜o, Cieˆncia e Tecnologia do Rio de Janeiro, Rua Prof. Carlos Wenceslau, 343, Realengo, Rio de Janeiro, RJ 21715-000, Brazil
A R T I C L E I N F O
Article history:
Received 10 March 2011
Accepted 11 August 2011
Available online 19 August 2011
Keywords:
Organophosphate
Mood disorders
Depression
Serotonin
Serotonergic system
Systemic toxicity
A B S T R A C T
Epidemiologic studies describe a potential risk of depression and suicide in farm workers exposed to
organophosphates (OPs). In a previous study we observed an increase in depressive-like behavior in
adult mice exposed to the OP pesticide methamidophos. Considering the association between
depression and the serotonergic (5HT) system, in the present study we investigated whether a
subchronic exposure to methamidophos affects the serotonergic system of adult mice. From postnatal
day 60 to 89 (PN60 to PN89), one of two concentrations of methamidophos (higher dose: 5.25 mg/ml;
lower dose: 1.31 mg/ml) or vehicle was administered in the drinking water of male Swiss mice. We
evaluated three serotonergic biomarkers during (PN89) and after (PN100) the exposure period: 5HT1A
receptor binding with [3H]OH-DPAT, 5HT2 receptor binding with [
3H]ketanserin and 5HT transporter
binding with [3H]paroxetine. Methamidophos elicited robust decreases in binding for all 5HT markers.
These decreases were evident in brain regions containing 5HT cell bodies and dendritic arbors (midbrain,
brainstem) as well as in the cerebral cortex, which contains 5HT projections. In the cerebral cortex,
effects were identiﬁed in mice exposed to the higher dose of methamidophos while in the midbrain and
brainstem, both doses elicited signiﬁcant effects. Overall, effects were present both during and after
exposure, even though there were some regional disparities regarding the persistence of effects. Our
results indicate that exposure to methamidophos affects synaptic transmission promoting decreases of
speciﬁc serotonergic biomarkers. These data suggest a mechanism of action of this pesticide that might
explain the increased depressive-like behavior in adult mice.
 2011 Elsevier Inc. 
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Organophosphate pesticides (OPs) are known to elicit neuro-
toxic actions with neurobehavioral consequences (Aldridge et al.,
2003, 2005a; Raines et al., 2001; Slotkin et al., 2006). In fact, the
effects of OP exposure during development have been widely
studied and the consequences include alterations in the motor
system, in sleep (Timofeeva and Gordon, 2002), in anxiety levels
(Braquenier et al., 2010) and in depressive-like behavior (Aldridge
et al., 2005a). It is increasingly clear that some of these ﬁndings are* Corresponding author at: Laborato´rio de Neuroﬁsiologia, Departamento de
Cieˆncias Fisiolo´gicas, Instituto de Biologia Roberto Alcantara Gomes, Centro
Biome´dico, Universidade do Estado do Rio de Janeiro, Av. Prof. Manoel de Abreu
444, 5 andar – Vila Isabel, Rio de Janeiro, RJ 20550-170, Brazil.
Tel.: +55 21 2587 6295; fax: +55 21 2587 6129.
E-mail address: yael_a_v@yahoo.com.br (Y. Abreu-Villac¸a).
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Open access under the Elsevier OA license.not restricted and may not even be related to the effects of the
inhibition of acetylcholinesterase (AChE), the enzyme responsible
for the breakdown of the neurotransmitter acetylcholine in the
central and peripheral nervous system (Sultatos, 1994), which is
the classical action of OP pesticides and which triggers the
cholinergic hyperstimulation typical of acute poisoning by OPs.
These agents also act as developmental neurotoxicants through a
family of mechanisms, some of which operate at exposures below
the threshold for cholinesterase inhibition (Slotkin, 2004, 2005). It
has been demonstrated that exposure to OPs such as diazinon,
parathion, chlorpyrifos and dichlorvos during prenatal or early
postnatal periods elicit widespread abnormalities in indices of
cholinergic, dopaminergic and serotonergic (5HT) synaptic func-
tion (Aldridge et al., 2005b; Levin et al., 2010; Slotkin and Seidler,
2008; Slotkin et al., 2008).
In spite of the fact that OPs have undergone several restrictions
regarding their use in several countries such as United States (U.S.
C.S. Lima et al. / NeuroToxicology 32 (2011) 718–724 719EPA, 2002) and Brazil (ANVISA Ageˆncia Nacional de Vigilaˆncia
Sanita´ria, 2004), these substances are still used worldwide and
account for about 25% of the insecticide world market value
(Casida et al., 2008), besides the existence of important OP
herbicides and fungicides (Casida et al., 2008). In this regard,
agricultural workers are at particular risk of exposure and, in
fact, epidemiologic studies suggest that the annual incidence of
pesticide poisonings among agricultural workers in developing
countries varies from 3 to 10%, so that a conservative estimative
suggests that 25 million pesticide poisonings occur among
agricultural workers each year in developing countries alone
(Koh and Jeyaratnam, 1996). Accordingly, besides the effects
during development, several important changes in glutamater-
gic, noradrenergic, dopaminergic and serotonergic systems
occur as a result of exposure at adulthood. Among these
changes are reductions of norepinephrine levels in rats exposed
to dichlorvos (Ali et al., 1980), increases in glutamate and GABA
uptake in rats exposed to methamidophos (Gubert et al., 2011)
and changes in dopamine metabolism and serotonin content and
turnover after exposure to chlorpyrifos (Moreno et al., 2008;
Pung et al., 2006). These ﬁndings suggest that the susceptibility
to OPs extends beyond the perinatal period, so that the central
nervous system of adults is still vulnerable to non-cholinester-
ase effects of OPs.
Several studies have reported an association between OP
exposure and psychiatric disorders (Amr et al., 1997; Fiedler
et al., 1997; London et al., 2005; Stephens et al., 1995).
Particularly, studies describe a potential risk of depression and
suicide in farm workers exposed to OPs (Jaga and Dharmani,
2007; London et al., 2005; van Wijngaarden, 2003). Despite that,
to our knowledge, a scant number of studies have investigated
the nature of the relation between psychiatric disorders and OP
exposure in animal models of OP exposure at adulthood. In a
previous study, our research group has identiﬁed depressive-like
behavior in adult mice subchronically exposed to low doses of
methamidophos (Lima et al., 2009), a highly toxic (class I) OP
which, in recent years, has been increasingly used as a
consequence of the prohibition of other pesticides. These results
reinforce evidence that there is an association between pesticide
exposure and psychiatric disorders, particularly depression
(Beseler et al., 2008; London et al., 2005; Ross et al., 2010).
Considering the behavioral changes we have observed and the
fact that the serotonergic system is a key system, deeply
associated with mood disorders, in the present study we
investigated whether the serotonergic system of adult mice is
altered by a subchronic exposure to the OP pesticide methami-
dophos at doses below the threshold for cholinergic hyperstimu-
lation. The analyses of the serotonergic system were performed
by the end of the period of exposure and after a period of recovery
in order to verify whether the effects persist or emerge post-
exposure. We evaluated indices of 5HT synaptic function in the
cerebral cortex, midbrain and brainstem. The cerebral cortex
contains major 5HT projections and the midbrain and brainstem,
in addition to 5HT dendritic arbors, contain the majority of the
serotonergic cell bodies of pathways that ascend into the cerebral
cortex, hippocampus and other regions involved in affective
disorders and serotonergic regulation of hypothalamus–pitui-
tary–adrenal axis function. We measured three 5HT synaptic
proteins: the 5HT1A and 5HT2 receptors, and the presynaptic 5HT
transporter (5HTT). The two receptors play major roles in 5HT-
related mental disorders, particularly depression (Arango et al.,
2001; Fujita et al., 2000; Mintun et al., 2004; Ohno, 2010; Yatham
et al., 1999, 2000), and the transporter, which regulates the
synaptic concentration of 5HT, is the primary target for
antidepressant drugs (Bab and Yirmiya, 2010; ICSI, 2011; Maes
and Meltzer, 1995; Nemeroff, 1998; Nutt, 2002; Ohno, 2010).2. Materials and methods
All experiments were carried out under institutional approval
of the Universidade do Estado do Rio de Janeiro in accordance with
the declaration of Helsinki and with the Guide for the Care and Use
of Laboratory Animals as adopted and promulgated by the National
Institutes of Health.
2.1. Animals and treatment (Fig. 1)
All mice were bred and maintained in a temperature controlled
environment, on a 12:12 h light/dark cycle (lights on at 2:00 a.m.).
Access to food and water was ad lib. On the ﬁrst postnatal day
(PN1), litters were culled to a maximum of eight mice to ensure
standard nutrition. At weaning (PN21) animals were separated by
sex and allowed free access to food and water. On PN60, males
were housed in groups of 2–4 animals to begin treatment. Previous
reports have demonstrated that OP exposure may elicit disparate
effects between males and females (Aldridge et al., 2004; Dam
et al., 2000; Levin et al., 2001; Meyer et al., 2004). Since agricultural
activities are essentially performed by men, who indeed receive
the most intense occupational exposures, while women participa-
tion is usually secondary, intermittent, and discontinuous (Chris-
man et al., 2009; ILO – International Labour Organization, 1999),
we opted to focus the study on male subjects.
One hundred forty-six male Swiss mice from 36 litters were
distributed into three treatment groups: higher dose (HighD),
lower dose (LowD) and control (CT). From PN60 to PN89, one of
two concentrations of methamidophos (Sigma, St. Louis, MO)
dissolved in methanol (HighD: 5.25 mg/ml; LowD: 1.31 mg/ml)
was administered in the drinking water (the sole source of ﬂuid).
The doses used are the same as those used in a previous study
which evaluated depressive-like behavior in male mice (Lima et al.,
2009). The doses were calculated based on the estimated ﬂuid
consumption of adult male Swiss mice so that the higher dose
delivered 7% and the lower dose delivered 1.8% of the DL50 value of
21 mg/kg (EXTOXNET, 1995). The CT group received methanol
dissolved in water at a concentration equivalent to that received by
the HighD group. Methanol consumption averaged 8.7 mg/day,
well below levels that produce neurotoxic effects (Burbacher,
1993; Shelby et al., 2004; Youssef and Santi, 1997). The present
experimental design does not allow us to discard the possibility
that methanol exposure affects the results. Despite that, there are
no studies describing an association between depression or
depressive-like symptomatology and methanol exposure, and
monoamine neurotransmission alterations in response to metha-
nol are described at doses at least ten times higher than the highest
dose used in our study (Jeganathan and Namasivayam, 1987,
1989). These ﬁndings suggest that it is unlikely that methanol
exposure, at the doses used here, has affected the results.
Bottles were cleaned and reﬁlled every other day. Body weights
and ﬂuid consumption during the period of exposure were also
measured every other day. As described elsewhere (Lima et al.,
2009), ﬂuid intake data were obtained by dividing the values of
ﬂuid intake of each cage by the combined body weight of the
animals of the cage. There were no differences in body weight and
ﬂuid consumption among groups; as a result, the higher
concentration of methamidophos in the drinking solution of the
HighD group resulted in a proportionally higher dose of the
methamidophos exposure when compared to the LowD group
(Lima et al., 2009).
Mice were decapitated at two time points, one toward the end
of treatment (PN89) and another eleven days after the end of
exposure (PN100). The time points used are the same as those used
in a previous study which evaluated depressive-like behavior in
male mice (Lima et al., 2009). The time point after the end of
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Fig. 1. Time-line of the experiment.
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In rat brain, the synthesis of new enzyme occurs with a mean half-
life of approximately 11 days (Giacobini, 2000). The brain regions
were dissected by making blunt cuts through the cerebellar
peduncles, whereupon the cerebellum (including ﬂocculi) was
lifted from the underlying tissue. The cerebral cortex (forebrain
with removal of the hippocampus) was separated from the
midbrain + brainstem by a cut made rostral to the thalamus. The
midbrain was then dissected from the hindbrain by making a cut
caudal to the inferior colliculus, so that the midbrain contained the
entire dorsal raphe nucleus but no descending serotonergic nuclei
(Fumagalli et al., 1996; Trauth et al., 2000). After tissue dissection,
cerebral cortex, midbrain and brainstem were frozen in liquid
nitrogen, and stored at 45 8C until assayed. For the midbrain and
brainstem, the biochemical assays were performed in ‘‘pool’’ tissue
from 2 mice. For each treatment group and period, 7–9 animals or
‘‘pools’’ were examined.
As described elsewhere (Lima et al., 2009), most animals
(n = 113) used in the present study were submitted to a sequence
of behavioral tests. Sacriﬁce occurred immediately after the
behavioral tests. Additional mice (n = 33) were distributed among
the treatment groups, submitted to the same procedures, except
for the behavioral tests, and sacriﬁced at the same time points as
those that were also submitted to the behavioral tests.
2.2. Tissue preparation and assays
Tissues were thawed and homogenized (Ultra-Turrax T10 basic,
IKA, Sa˜o Paulo, SP) in ice-cold 50 mM Tris (pH 7.4), and
homogenates were sedimented at 40,000  g for 15 min. The
pellets were washed by resuspension (Ultra-Turrax) in homogeni-
zation buffer followed by resedimentation, and were then
dispersed with a homogenizer (smooth glass ﬁtted with Teﬂon
pestle) in the same buffer. An aliquot was assayed for measure-
ment of membrane protein (Smith et al., 1985).
Two radioligands were used to determine 5HT receptor
binding: 1 nM [3H]8-hydroxy-2-(di-n-propylamino)tetralin for
5HT1A receptors, and 0.4 nM [
3H]ketanserin for 5HT2 receptors.
Binding to the presynaptic 5HT transporter was evaluated with
85 pM [3H]paroxetine (Aldridge et al., 2005c). For 5HT1A receptors,
incubations lasted for 30 min at 25 8C in a buffer consisting of
50 mM Tris (pH 8), 0.5 mM MgCl2, and 0.5 mM sodium ascorbate;
100 mM 5HT was used to displace speciﬁc binding. For 5HT2
receptors, incubations lasted 15 min at 37 8C in 50 mM Tris (pH
7.4) and speciﬁc binding was displaced with 10 mM methysergide.
For binding to the presynaptic 5HT transporter, incubations lasted
for 120 min at 20 8C in a buffer consisting of 50 mM Tris (pH 7.4),
120 mM NaCl, and 5 mM KCl; 100 mM 5HT was used to displacespeciﬁc binding. Incubations were stopped by the addition of
excess of ice-cold incubation buffer (without radioligand or
displacing agent) and the labeled membranes were trapped by
rapid vacuum ﬁltration onto glass ﬁber ﬁlters that were presoaked
in 0.15% polyethyleneimine. The ﬁlters were then washed with
incubation buffer and radiolabel was determined (Aldridge et al.,
2005c).
The overall strategy was to examine binding at a single ligand
concentration in preparations from all regions in every animal/
pool, focusing on a concentration above the Kd but below full
saturation. We can thus detect changes that originate either in
altered Kd or Bmax but cannot distinguish between the two possible
mechanisms. In spite of this limitation, the interpretation of results
of the present study does not depend upon whether the changes
are speciﬁc to concentration or afﬁnity. This strategy was needed
due to the amount of tissue available for each determination and
due to technical limitations caused by the requirement to measure
binding in three treatment groups at two different ages in multiple
brain regions, with at least six animals. Thus, there were hundreds
of separate membrane preparations, each of which had to be
evaluated for binding of three different ligands.
2.3. Material
Radioisotopically labeled compounds came from PerkinElmer
Life Sciences (Boston, MA): [3H]8-hydroxy-2-(di-n-propylamino)-
tetralin (speciﬁc activity 170.2 Ci/mmol), [3H]ketanserin (speciﬁc
activity 67.0 Ci/mmol) and [3H]paroxetine (speciﬁc activity,
24.4 Ci/mmol). Sigma Chemical Co. (St. Louis, MO) was the source
for bovine albumin, BCA kit, methamidophos, serotonin, methyl-
sergide and polyethyleneimine. VETEC Quı´mica Fina Ltda (Rio de
Janeiro, RJ) was the source for all other reagents.
2.4. Statistical analysis
All data were compiled as means and standard errors.
Signiﬁcance was assumed at the level of P < 0.05. Initially,
analyses of variance (ANOVA) on each variable (5HT1A receptors,
5HT2 receptors and the 5HT transporter) were carried out.
Treatment (high dose, low dose and control) and Period (during
and after exposure) were used as between-subjects factors.
Whenever applicable, signiﬁcant Treatment  Period interactions
were followed by lower order ANOVAs and by pairwise post hoc
analyses by using Fisher’s Protected Least Signiﬁcant Difference
(FPLSD). Main Treatment effects were followed by FPLSD. To
facilitate comparisons across the different measurements, the
effects of methamidophos were compiled as the percent change
from control values, but statistical evaluations involved only the
Table 1
Control values for serotonergic biomarkers.
During exposure After exposure
5HT1A 5HT2 5HTT 5HT1A 5HT2 5HTT
Cortex 25.3  1.2 38.2  3.0 191.8  9.1 26.5  1.3 39.9  2.5 198.9  7.8
Midbrain 12.5  1.1 22.9  3.9 411.5  19.5 10.1  1.1 24.4  2.4 380.5  14.9
Brainstem 13.1  1.0 13.9  1.1 226.1  12.4 9.9  0.4 14.3  1.1 219.5  7.1
Values are mean  SEM in fmol/mg of protein.
C.S. Lima et al. / NeuroToxicology 32 (2011) 718–724 721original data; for reference, control values for all variables are
shown in Table 1.
3. Results
Treatment of adult male mice with methamidophos had
profound effects on 5HT synaptic markers. The cerebral cortex
(Fig. 2), a brain region containing a considerable number of 5HT
projections, showed signiﬁcant reductions in binding sites for
5HT1A receptors (Treatment: F2,36 = 3.4, P = 0.04), 5HT2 receptors
(Treatment: F2,42 = 7.1, P = 0.002) and 5HTT (Treatment: F2,42 = 7.1,
P = 0.002; Treatment  Period: F2,42 = 4.3, P = 0.02). All signiﬁcant
results were identiﬁed in mice exposed to the higher dose of
methamidophos: The HighD group presented reduced 5HT1A and
5HT2 receptor binding during exposure, an effect that persisted
even eleven days post-treatment. The LowD group did not differ
from the CT group, even though there was a trend for reduced
binding for 5HT1A receptors. The effects on 5HTT only reached
signiﬁcance eleven days post-exposure when again the HighD
group presented reduced binding when compared to the CT group.
Methamidophos treatment also elicited robust reductions in
5HT binding markers in brain regions containing 5HT cell bodies
and dendritic arbors; however, in these regions, both doses elicited
signiﬁcant alterations: In the midbrain (Fig. 3), 5HT2 (Treatment:
F2,46 = 7.8, P = 0.001) and 5HTT (Treatment: F2,48 = 10.9, P = 0.001;
Treatment  Period: F2,48 = 4.4, P = 0.02) binding sites were
reduced, while there were no signiﬁcant reductions for 5HT1A:
Both the HighD and the LowD groups presented a reduction in
binding for 5HT2 receptors and this effect was still evident eleven
days post-treatment. The reduction in binding sites for 5HTT was
evident for both HighD and LowD groups during exposure butFig. 2. Effects of methamidophos subchronic exposure on 5HT1A receptors, 5HT2
receptors and 5HT transporter (5HTT) binding in the cerebral cortex during and
after exposure of adult male mice, presented as the percent change from control
values. For 5HT1A and 5HT2 receptors, only a Treatment effect was detected,
accordingly, differences among groups (Control, LowD, and HighD) were followed
by FPLSD tests on groups collapsed across periods. For 5HTT, a Treatment  Period
interaction was detected, so that differences among subgroups (Control during
exposure, Control after exposure, LowD during exposure, LowD after exposure,
HighD during exposure and HighD after exposure) were followed by FPLSD tests.
Values are means  SEM. *P < 0.05, **P < 0.01 vs. Control group. AS (approaching
signiﬁcance) P > 0.05 < 0.10 vs. Control group. LowD during: lower dose during
exposure; LowD after: lower dose after exposure; HighD during: higher dose during
exposure; HighD after: higher dose after exposure groups.failed to persist after the end of treatment. In the brainstem (Fig. 4),
all serotonergic markers were affected (5HT1A – Treatment:
F2,38 = 9.4, P = 0.005 and Treatment  Period: F2,38 = 7.4,
P = 0.002; 5HT2 – Treatment: F2,40 = 6.5, P = 0.004; 5HTT –
Treatment: F2,41 = 16.2, P < 0.0001): Both HighD and LowD groups
showed signiﬁcant reductions in 5HT1A receptor binding during
methamidophos exposure but no alterations were observed after
the end of treatment. For 5HT2 receptors and the 5HTT, both doses
elicited a reduction in binding during and after exposure.
4. Discussion
Epidemiologic studies suggest that farm workers are prone to
develop depressive disorders. In the present study, we describe
that the serotonergic system of adult mice is altered by a
subchronic exposure to the OP pesticide methamidophos at doses
below the threshold for cholinergic hyperstimulation. Considering
that in a previous study we observed an increase in the depressive-
like behavior of mice exposed to methamidophos at adulthood,
which reinforces the hypothesis that OP exposure is associated
with an increased risk of depression, our current ﬁndings are
consistent with the view that the disruption of the serotonergic
function by methamidophos plays a role in the depressive-like
symptomatology identiﬁed in adult mice.
Even though the classic, toxic effects of OPs are caused by the
inhibition of AChE, it is increasingly clear that OPs also act through
multiple mechanisms, not necessarily related to AChE inhibition,
that culminate in biochemical and/or behavioral deﬁciencies.
Regarding the serotonergic system, there is evidence that the
effects are highly dependent on the OP, so that the direction of the
alteration and the magnitude of the effect may be different amongFig. 3. Effects of methamidophos subchronic exposure on 5HT1A receptors, 5HT2
receptors and 5HT transporter (5HTT) binding in the midbrain during and after
exposure of adult male mice, presented as the percent change from control values.
For 5HT2 receptors, only a Treatment effect was detected, accordingly, differences
among groups (Control, LowD and HighD) were followed by FPLSD tests on groups
collapsed across periods. For 5HTT, a Treatment  Period interaction was detected,
so that differences among subgroups (Control during exposure, Control after
exposure LowD during exposure, LowD after exposure, HighD during exposure and
HighD after exposure) were followed by FPLSD tests. Values are means  SEM.
**P < 0.01, ***P < 0.001 vs. Control group. LowD during: lower dose during exposure;
LowD after: lower dose after exposure; HighD during: higher dose during exposure;
HighD after: higher dose after exposure groups.
Fig. 4. Effects of methamidophos subchronic exposure on 5HT1A receptors, 5HT2
receptors and 5HT transporter (5HTT) binding in the brainstem during and after
exposure of adult male mice, presented as the percent change from control values.
For 5HT1A, a Treatment  Period interaction was detected, so that differences
among subgroups (Control during exposure, Control after exposure LowD during
exposure, LowD after exposure, HighD during exposure and HighD after exposure)
were followed by FPLSD tests. For 5HT2 receptors and 5HTT, only a Treatment effect
was detected, accordingly, differences among groups (Control, LowD and HighD)
were followed by FPLSD tests on groups collapsed across periods. Values are
means  SEM. **P < 0.01, ***P < 0.001 vs. Control group. LowD during: lower dose
during exposure; LowD after: lower dose after exposure; HighD during: higher dose
during exposure; HighD after: higher dose after exposure groups.
C.S. Lima et al. / NeuroToxicology 32 (2011) 718–724722distinct OPs (Levin et al., 2010; Slotkin and Seidler, 2008; Slotkin
et al., 2009). Besides the OP used, there may be differences among
effects according to the stage of development. Here, we found that
methamidophos exposure at adulthood elicited a reduction in
serotonergic receptors and presynaptic transporter binding.
Distinctively, Slotkin et al. (2009) described that neonatal exposure
to parathion elicited upregulation of 5HT receptors in adolescent
rats and downregulation at adulthood. Neonatal diazinon exposure
evoked downregulation of the 5HT1A receptor in male rats
accompanied by upregulation of the 5HT transporter in females
(Slotkin et al., 2008) while the effects of chlorpyrifos include
suppression of serotonergic biomarkers when exposure occurs
early in gestation and increase in 5HT1A and 5HT2 binding due to
neonatal exposure (Aldridge et al., 2003).
Here, robust changes in serotonergic biomarkers were identi-
ﬁed even when there was little inhibition of AChE. As an example,
in our previous study, we showed that the lower dose group
presented 15% inhibition of AChE activity during exposure (Lima
et al., 2009) and in the present study this group presented a robust
reduction in 5HT2 receptor binding relative to the control group
(e.g. 42% in the midbrain). Eleven days after exposure, AChE
activity was recovered (Lima et al., 2009) while the alteration of the
serotonergic receptor was still evident (e.g. 32% in the midbrain).
Altogether, these results corroborate previous ﬁndings during
development that suggest that the alterations in the serotonergic
system are not related to the inhibition of AChE.
Interestingly, despite the fact that occupational contamination
by pesticides is more frequent at adulthood (Dharmani and Jaga,
2005), the investigation of biochemical alterations promoted by
OPs is scarce at this stage. Our ﬁndings indicate that the
serotonergic system is sensitive to the methamidophos OP at
adulthood. It is well established that 5HT receptors are altered in
depressive disorders (for review: Carr and Lucki, 2010; Savitz et al.,
2009). In these situations, a depletion of serotonin may lead to a
compensatory increase in the density or afﬁnity of target receptors
(upregulation) (Arora and Metzer, 1989; Matsubara et al., 1991;
Pandey et al., 2002), which is in a clear contrast to our current
ﬁndings. Interestingly, the upregulation of receptors may not be
the only alteration associated with impaired serotonergic trans-
mission. A recent study that evaluated the mRNAs encoding the
proteins for serotonin biosynthesis, storage and degradation, as
well as for 5HT receptors in undifferentiated and differentiating
PC12 cells exposed to chlorpyrifos or diazinon described that bothagents increase the expression of genes that encode tryptophan
hydroxylase, the rate-limiting enzyme in serotonin biosynthesis,
suppress the expression of 5HT transporter genes and that
diazinon evokes overall suppression of 5HT receptor subtypes
(Slotkin and Seidler, 2008). Furthermore, a decreased expression of
the mRNA encoding the 5HT1A receptor (Lo´pez-Figueroa et al.,
2004) and in 5HT2A receptor binding (Mintun et al., 2004) in
patients with major depression were demonstrated. One possible
explanation for the present results is that the initial event elicited
by methamidophos is the reduced 5HTT binding. As a result of the
decrease in serotonin uptake, serotonin accumulates in the
synaptic cleft, which would lead ultimately to a downregulation
of receptors. However, we cannot discard the possibility that our
results reﬂect a direct action of methamidophos on other
components of the serotonergic system.
Regarding the action of OPs on neurotransmitter levels,
chlorpyrifos was shown to elicit an increase in serotonin content
in the cerebral cortex and a decrease in the hippocampus of adult
rats (Pung et al., 2006). Late-emergent decreases in serotonin
content in the nucleus accumbens and in serotonin turnover (given
by the ratio metabolite/neurotransmitter that represents a
dynamic index of synaptic activity) in the striatum were also
described (Moreno et al., 2008). Aldridge et al. (2005b) detected
decreased content and increased serotonin turnover in several
brain regions of adult rats exposed to chlorpyrifos during the
gestational period. Gestational exposure to chlorpyriphos elicited
an increased turnover of 5HT in the cerebral cortex, midbrain,
brainstem and hippocampus of adolescent male rats (Slotkin and
Seidler, 2007b). In addition, a more recent study found increased
turnover of serotonin in the brainstem during the weaning period
of rats exposed to chlorpyrifos later during development (PN11 to
PN14) (Slotkin and Seidler, 2007a). If similar events occur due to
methamidophos exposure, it is possible that our results are a
consequence, at least in part, of changes in serotonin levels and/or
turnover. Since we identiﬁed decreased serotonergic biomarkers,
we would expect to ﬁnd increased neurotransmitter levels. This
effect could be associated with decreased turnover, however, it is
also possible that a compensatory increase in turnover takes place
as a result of long-term exposure at adulthood.
In a previous study using the same experimental design used in
the present study (Lima et al., 2009) we have detected increased
depressive-like behavior both during and after exposure to
methamidophos at adulthood: Mice exposed to the lower dose
presented increased depressive-like behavior during exposure
while the higher dose elicited increased depressive-like behavior
after the end of exposure. As we have shown in the present study,
these behavioral effects were paralleled by the decreased binding
of receptors and the serotonergic transporter both in the brain
region rich in serotonergic projections (cerebral cortex) and in
regions rich in serotonergic cell bodies (brainstem and midbrain),
which suggests that the behavioral and biochemical alterations are
associated. Among 5HT receptors, evidence for a role in the
pathogenesis and treatment of depressive disorders is more
extensive for 5HT1A and 5HT2 receptors. Besides, serotonin
reuptake inhibitors, which act at the 5HTT, are the ﬁrst-line drugs
in the treatment of depression, while agonists at 5HT1A receptors
have been reported to exert antidepressive activity in double-
blind, placebo-controlled, and comparative trials (Blier and Ward,
2003). In addition, there is evidence of altered 5HT1A and 5HT2
receptor as well as 5HTT binding in brain regions of suicide victims
and in patients with major depression (Arango et al., 2001; Malison
et al., 1998; Mintun et al., 2004; Yatham et al., 2000). Even though
it is not established whether serotonergic alterations precede
depressive symptoms or result from depressive episodes, the
present results reinforce an association between serotonergic and
behavioral alterations. Despite that, some biochemical alterations
C.S. Lima et al. / NeuroToxicology 32 (2011) 718–724 723were not accompanied by behavioral effects, which might indicate
that other serotonergic alterations or even alterations in other
neurotransmitter systems play a role. In this regard, in addition to
the changes in serotonin levels and turnover described above for
OPs other than methamidophos (Aldridge et al., 2005b; Slotkin and
Seidler, 2007a,b) OP exposure has been associated with dopami-
nergic and noradrenergic alterations (Ali et al., 1980; Moreno et al.,
2008; Pung et al., 2006; Slotkin and Seidler, 2007b). Finally, several
effects on serotonergic markers that were present during exposure
were still detectable after exposure. However, some markers seem
to recover post-exposure; particularly the 5HTT in the midbrain
and the 5HT1A in the brainstem. These results suggest that recovery
is more efﬁcient in regions rich in serotonergic cell bodies, where
serotonergic proteins are synthesized.
5. Conclusions
Many studies that investigate the impact of OP exposure on the
serotonergic system focus on the effects of these substances during
the perinatal period (for review: Slotkin, 2004; Slotkin and Seidler,
2007c). However, occupational contamination by OP pesticides is
more frequent at adulthood (Dharmani and Jaga, 2005). Our results
indicate that methamidophos is deleterious to brain function and
that susceptibility can also occur at adulthood, a period generally
considered to be of greater resistance to low dose effects, as
opposed to the perinatal period. Considering the association
between the serotonergic system and depression, the present
results, together with previous ﬁndings describing behavioral
alterations consistent with depressive-like behavior due to OP
exposure (Brocardo et al., 2007; Lima et al., 2009; Ramos et al.,
2006) suggest that exposure to pesticides, particularly those in the
OP class, should be taken into account in designing health
programs that aim to prevent and control mental disorders in
rural populations, especially among those that work in the ﬁelds.
Considering that the ill effects of exposure could take a long time to
manifest, such programs should include long-term follow-ups.
Furthermore, legislation addressing maximum exposure levels to
OP should take into account that even low doses can be harmful to
adult humans.
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